Andrew J. Schwab

Companies

• Camp4 Therapeutics CorpBoard member Oct 10, 2024 to now¹
• Skye Bioscience, Inc.Board member Aug 22, 2023 to now²
• Enliven Therapeutics, Inc.Board member Feb 27, 2023 to Apr 6, 2023³
• Pear Therapeutics (United States)Board member Dec 7, 2021 to Dec 7, 2021⁴
• 5:01 Acquisition Corp.Board member Oct 13, 2020 to Dec 1, 2020⁵
• 5:01 Acquisition Corp.Chief executive officer Oct 13, 2020 to Dec 1, 2020⁵
• Flexion TherapeuticsBoard member Feb 11, 2014 to Mar 4, 2014⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ETEnliven Therapeutics, Inc. ELVN887,507 shares⁷$34.0M at $38.33Aug 24, 2023
• SBSkye Bioscience, Inc. SKYE981,269 shares⁸$1.5M at $1.53Sep 24, 2026
• CTCamp4 Therapeutics Corp CAMP302,770 shares⁹$962.8K at $3.18Aug 31, 2026
• PTPear Therapeutics (United States)3,372,769 shares¹⁰Aug 18, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 23, 2026Sold 4,528 shares at $1.61 of Skye Bioscience, Inc.⁸
• Sep 23, 2026Sold 114,851 shares at $1.61 of Skye Bioscience, Inc.⁸
• Sep 22, 2026Sold 1,088 shares at $1.65 of Skye Bioscience, Inc.⁸
• Sep 22, 2026Sold 27,612 shares at $1.65 of Skye Bioscience, Inc.⁸
• Sep 16, 2026Sold 1,285 shares at $1.91 of Skye Bioscience, Inc.¹¹
• Sep 16, 2026Sold 32,607 shares at $1.91 of Skye Bioscience, Inc.¹¹
• Aug 27, 2026Sold 400,000 shares at $4.04 of Camp4 Therapeutics Corp⁹
• Aug 24, 2026Sold 10 shares at $4.50 of Camp4 Therapeutics Corp¹²
• Aug 21, 2026Sold 32,018 shares at $4.50 of Camp4 Therapeutics Corp¹³
• Aug 20, 2026Sold 6,495 shares at $0.32 of Skye Bioscience, Inc.¹⁴
• Aug 20, 2026Sold 46 shares at $0.32 of Skye Bioscience, Inc.¹⁴
• Aug 20, 2026Sold 1,159 shares at $0.32 of Skye Bioscience, Inc.¹⁴
• Aug 20, 2026Sold 114,700 shares at $4.54 of Camp4 Therapeutics Corp¹³
• Aug 19, 2026Sold 57,476 shares at $0.35 of Skye Bioscience, Inc.¹⁴
• Aug 19, 2026Sold 409 shares at $0.35 of Skye Bioscience, Inc.¹⁴
• Aug 19, 2026Sold 10,255 shares at $0.35 of Skye Bioscience, Inc.¹⁴
• Aug 19, 2026Sold 45,147 shares at $4.76 of Camp4 Therapeutics Corp¹³
• Aug 18, 2026Sold 253,080 shares at $0.38 of Skye Bioscience, Inc.¹⁴
• Aug 18, 2026Sold 1,830 shares at $0.38 of Skye Bioscience, Inc.¹⁴
• Aug 18, 2026Sold 45,090 shares at $0.38 of Skye Bioscience, Inc.¹⁴
• Sep 11, 2025Granted 2,941,176 shares at $1.53 of Camp4 Therapeutics Corp¹⁵
• Aug 22, 2025Sold 6,470 shares at $3.42 of Skye Bioscience, Inc.¹⁶
• Aug 22, 2025Sold 163,979 shares at $3.42 of Skye Bioscience, Inc.¹⁶
• Aug 21, 2025Sold 2,314 shares at $3.57 of Skye Bioscience, Inc.¹⁶
• Aug 21, 2025Sold 58,642 shares at $3.57 of Skye Bioscience, Inc.¹⁶